GlassScriptPhysician profile
Karuna Ahuja
NPI 1497794648
$7,793.10
in general payments reported to CMS, 2019-2025
42 companies · $1,398 in 2025
The $1,398 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $998 · 2020: $815 · 2021: $1,573 · 2022: $938 · 2023: $864 · 2024: $1,208 · 2025: $1,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,344 · Education: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,344.49 |
| Education | $125.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,329.63 | 2019-2025 | Nucala, Trelegy Ellipta, Benlysta |
| Astrazeneca Pharmaceuticals LP | $1,169.23 | 2019-2025 | Tezspire, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $751.56 | 2019-2025 | Ofev, Spiriva Respimat |
| Harmony Biosciences LLC | $628.26 | 2020-2025 | Wakix |
| Grifols USA, LLC | $460.35 | 2019-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $379.76 | 2021-2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $359.30 | 2019-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $261.40 | 2022-2025 | Glassia |
| Jazz Pharmaceuticals INC. | $216.79 | 2019-2024 | |
| Insmed, INC. | $205.82 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $189.94 | 2022-2025 | |
| Edwards Lifesciences Corporation | $126.35 | 2021 | |
| Philips North America LLC | $119.66 | 2020-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Mylan Specialty L.P. | $116.76 | 2019-2024 | Yupelri |
| Polynovo North America LLC | $106.85 | 2024 | Novosorb Btm |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $102.63 | 2021-2022 | |
| Roche Diagnostics Corporation | $99.87 | 2019 | |
| Pulmonx Corporation | $98.72 | 2022-2025 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Cvrx, INC. | $92.91 | 2022-2024 | Barostim Neo System |
| Teva Pharmaceuticals USA, INC. | $92.37 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $82.66 | 2021-2025 | Verquvo, Belsomra, Winrevair |
| Axsome Therapeutics, INC. | $81.47 | 2023-2025 | Sunosi |
| United Therapeutics Corporation | $69.93 | 2025 | Tyvaso |
| Genentech USA, INC. | $62.81 | 2019 | |
| Electromed, INC. | $62.77 | 2021-2023 | Smartvest |
| Viatris Specialty LLC | $58.35 | 2025 | Yupelri |
| Ani Pharmaceuticals, INC. | $47.39 | 2022-2025 | Purified Cortrophin Gel |
| Baxter Healthcare | $46.24 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Circassia INC. | $41.38 | 2019-2020 | |
| Resmed Corp | $39.56 | 2023-2024 | |
| Abiomed | $39.02 | 2025 | |
| Inspire Medical Systems, INC. | $34.16 | 2023-2025 | Inspire |
| Janssen Pharmaceuticals, INC | $33.90 | 2020-2021 | |
| Advanced Respiratory, INC | $33.15 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $26.86 | 2025 | Uptravi |
| Alnylam Pharmaceuticals INC. | $22.88 | 2023 | Givlaari |
| Shire North American Group INC | $21.47 | 2019 | |
| Abbvie INC. | $17.97 | 2021 | |
| Ardelyx, INC. | $17.82 | 2025 | Ibsrela |
| Lilly USA, LLC | $17.61 | 2025 | Zepbound |
| Amgen INC. | $15.14 | 2025 | Tezspire |
| Allergan, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karuna Ahuja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.